Jove
Visualize
Contact Us

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

75
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
75
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence01:19

Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence

223
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
223
Cleaning, Sterilization, and Disinfection01:30

Cleaning, Sterilization, and Disinfection

13.3K
Cleaning, disinfection, and sterilization are the methods that help to break the infection chain and prevent disease.
Cleaning
The cleaning process usually involves using water with detergents or enzymatic cleaner and removing foreign material from objects and surfaces, including organic material such as body fluids or inorganic material like soil. Cleaning is performed before high-level disinfection and sterilization because foreign materials on the cover of the devices interfere with process...
13.3K
Contaminants and Errors01:16

Contaminants and Errors

535
Effective sample preparation is crucial for accurate and reliable laboratory analysis. During this process, two significant sources of error can arise: concentration bias from improper sample splitting and contamination caused by methods used to reduce particle size, such as grinding or homogenization. Identifying and minimizing these potential errors is crucial to ensuring the validity of the analysis.
Another key consideration is determining the appropriate number of samples required to...
535
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence01:22

Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence

239
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
239
Methods of Sterilization II: Chemical Methods01:30

Methods of Sterilization II: Chemical Methods

10.6K
In healthcare, the chemical method of sterilization uses chemical sterilants to treat surgical instruments and medical supplies to help prevent the transmission of infectious pathogens to patients. Due to heat sensitivity, most medical supplies and equipment should not be exposed to high temperatures. These parts include rubber, plastic, glass, and other similar elements.
Using chemical sterilization rather than heat to clean out equipment is recommended. It eradicates and removes all bacteria,...
10.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Contaminant Organism Growth in Febrile Infants at Low Risk for Invasive Bacterial Infection.

The Journal of pediatrics·2024
Same author

Drug Utilization Review: Our Patients Deserve Our Very Best.

International journal of pharmaceutical compounding·2023
Same author

Race, Ethnicity, Language, and the Treatment of Low-Risk Febrile Infants.

JAMA pediatrics·2023
Same author

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA.

International journal of pharmaceutical compounding·2021
Same author

Performing a United States Pharmacopeia Chapter <800> Compliant Assessment of Risk.

International journal of pharmaceutical compounding·2020
Same author

Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.

Gut·2016
Same journal

Compounding and Stability Study of Dipyridamole and Clopidogrel Pediatric Oral Suspensions.

International journal of pharmaceutical compounding·2026
Same journal

Nanoemulsion Reformulation of Nitrosylcobalamin (NO-Cbl) Enhances Solubility, Stability, and Anti-Tumor Potency.

International journal of pharmaceutical compounding·2026
Same journal

Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations.

International journal of pharmaceutical compounding·2026
Same journal

Stability Evaluation of Compounded Benzocaine, Lidocaine, and Tetracaine in VersaPro™ Cream Base.

International journal of pharmaceutical compounding·2026
Same journal

Formulation and In-Vitro Characterization of Gastroretentive Effervescent Floating Tablets of Meloxicam.

International journal of pharmaceutical compounding·2026
Same journal

Ethical and Regulatory Implications of Sourcing Drug X During an FDA-Reported Shortage: 503A vs. 503B Compounding Facilities.

International journal of pharmaceutical compounding·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 25, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.7K

Root Cause Analysis, Part 1: Nonsterile Compounding.

Joe Cabaleiro, Kathleen Jackson

    International Journal of Pharmaceutical Compounding
    |February 20, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Preventing pharmacy errors requires identifying the root cause of adverse events and near misses. This article introduces a method for Root Cause Analysis to avoid recurring patient safety risks.

    More Related Videos

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
    07:00

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

    Published on: August 11, 2017

    8.8K
    Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System
    08:48

    Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System

    Published on: December 21, 2016

    9.3K

    Related Experiment Videos

    Last Updated: Mar 25, 2026

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
    09:30

    Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

    Published on: March 17, 2023

    4.7K
    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface
    07:00

    Failure of Cleaning Verification in Pharmaceutical Industry Due to Uncleanliness of Stainless Steel Surface

    Published on: August 11, 2017

    8.8K
    Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System
    08:48

    Analysis of the Ambient Particulate Matter-induced Chromosomal Aberrations Using an In Vitro System

    Published on: December 21, 2016

    9.3K

    Area of Science:

    • Pharmacy Practice
    • Patient Safety
    • Quality Improvement

    Background:

    • Adverse events and near misses are significant concerns in pharmacy operations.
    • Superficial problem-solving in pharmacies risks recurrent patient harm.
    • Effective root cause identification is crucial for preventing future incidents.

    Purpose of the Study:

    • To propose a systematic method for conducting Root Cause Analysis (RCA) in pharmacy settings.
    • To provide a framework for addressing the fundamental causes of pharmacy errors.
    • To enhance patient safety by preventing the recurrence of adverse events and near misses.

    Main Methods:

    • The article outlines a structured approach to Root Cause Analysis.
    • Key steps involve identifying the event, gathering data, determining causal factors, and developing solutions.
    • Emphasis is placed on moving beyond surface-level corrections to uncover underlying system issues.

    Main Results:

    • The proposed RCA method facilitates a deeper understanding of deviation causes.
    • Implementation of the method aims to reduce the likelihood of similar events.
    • Addresses the critical need for thorough investigation of pharmacy errors.

    Conclusions:

    • A robust Root Cause Analysis is essential for effective risk management in pharmacies.
    • This method provides a practical tool for pharmacies to improve safety protocols.
    • Proactive identification and mitigation of root causes protect patients and optimize pharmacy practice.